Activmed Practices & Research, Inc.

1. Amgen Inc. $13,823 3 payments
2. Celgene Corporation $12,368 1 payment
3. Akebia Therapeutics Inc $10,860 3 payments
4. Kiniksa Pharmaceuticals International, plc $3,377 2 payments
5. Kiniksa Pharmaceuticals, Ltd. $644 8 payments
6. Merck Sharp & Dohme Corporation $566 2 payments
7. Guerbet LLC $416 2 payments

1. A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Apremilast (Cc-10004) in Pediatric Subjects From 6 Through 17 Years With Moderate to Severe Plaque Psoriasis (Cc-10004-Ppso-003) $12,368 1 payment
2. Akb-6548-Ci-0015 $10,860 3 payments
3. A Study of the Efficacy and Safety of Apremilast CC-10004 in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp STYLE $9,978 1 payment
4. A Phase 2a/b, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of KPL-716 in Reducing Pruritis in Subjects with Prurigo Nodularis $4,021 10 payments
5. An Efficacy and Safety Study of Apremilast CC-10004 in Subjects With Moderate to Severe Genital Psoriasis DISCREET $3,845 2 payments
6. TECOS# A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Mono- or Dual Combination Oral Antihyperglycemic Therapy $566 2 payments
7. Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years (ODYSSEY) $416 2 payments

1. Patient care $416 2 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.